Definium Therapeutics Inc.
DFTX | NASDAQ
$33.65
-$2.68 (-7.38%)
Nov 2, 2026, 12:09 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 527K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -527K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -75.08M | -59.22M | -47.58M | -45.67M | -40.9M | -32.16M | -32.46M | -24.79M | -24.46M | -22.2M | -22.21M | -21.62M | -29.18M | -20.86M | -13.9M | -16.98M | -16.94M | -18.51M | -17.56M | -17.23M | -45.22M | -13.85M |
Interest Income | 3.59M | 3.46M | 3.49M | 2.26M | 2.77M | 2.43M | 3.28M | 3.51M | 3.12M | 1.66M | 905K | 1.49M | 1.39M | 1.36M | 1.05M | 360K | 82K | n/a | -27K | n/a | n/a | 22K |
Pretax Income | -158.99M | -77.1M | -50.44M | -67.27M | -42.74M | -23.35M | -34.74M | -13.68M | -5.85M | -54.4M | -23.86M | -17.92M | -29.13M | -24.82M | -4.9M | -16.49M | -16.96M | -18.45M | -17.99M | -17.2M | -45.25M | -13.76M |
Net Income | -158.99M | -77.1M | -50.44M | -67.27M | -42.74M | -23.35M | -34.74M | -13.68M | -5.85M | -54.4M | -23.86M | -17.92M | -29.13M | -24.82M | -4.9M | -16.49M | -16.96M | -18.45M | -16.83M | -17.2M | -45.25M | -13.76M |
Selling & General & Admin | 26.41M | 17.74M | 14.06M | 14.69M | 11.09M | 8.8M | 10.7M | 7.6M | 9.81M | 10.5M | 10.66M | 8.41M | 14.41M | 8.26M | 5.07M | 9.21M | 7.62M | 8.26M | 6.68M | 8.21M | 37.15M | 6.74M |
Research & Development | 48.67M | 41.48M | 33.52M | 30.98M | 29.81M | 23.36M | 21.76M | 17.19M | 14.65M | 11.18M | 11.55M | 13.2M | 14.78M | 12.6M | 8.83M | 7.77M | 9.33M | 10.24M | 10.88M | 9.02M | 8.07M | 6.81M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 300K |
Operating Expenses | 75.08M | 59.22M | 47.58M | 45.67M | 40.9M | 32.16M | 32.46M | 24.79M | 24.46M | 21.68M | 22.21M | 21.62M | 29.18M | 20.86M | 13.9M | 16.98M | 16.94M | 18.51M | 17.56M | 17.23M | 45.22M | 13.85M |
Interest Expense | 1.23M | 1.25M | 9.7M | 1.27M | 2.34M | 602K | 656K | 727K | 466K | 434K | n/a | 328K | 77K | 76K | n/a | n/a | n/a | 27K | 359K | 64K | 69K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 75.08M | 59.22M | 47.58M | 45.67M | 40.9M | 32.16M | 32.46M | 24.79M | 24.46M | 22.2M | 22.21M | 21.62M | 29.18M | 20.86M | 13.9M | 16.98M | 16.94M | 18.51M | 17.56M | 17.23M | 45.22M | 13.85M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.16M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 110.68M | 108.79M | 89.33M | 85.89M | 85.35M | 85.07M | 83.93M | 77.91M | 71.91M | 47.86M | 40.28M | 39.72M | 38.58M | 38.08M | 37.98M | 29.3M | 28.24M | 28.15M | 28.05M | 28M | 27.04M | 25.94M |
Shares Outstanding (Diluted) | 110.68M | 108.79M | 89.33M | 85.89M | 85.35M | 87.09M | 83.93M | 80.24M | 71.91M | 47.86M | 40.28M | 39.72M | 38.58M | 38.08M | 37.98M | 29.3M | 28.24M | 28.15M | 28.05M | 28.01M | 27.39M | 25.97M |
EPS (Basic) | -1.44 | -0.71 | -0.51 | -0.78 | -0.50 | -0.27 | -0.41 | -0.18 | -0.08 | -1.14 | -0.59 | -0.45 | -0.76 | -0.65 | -0.13 | -0.55 | -0.60 | -0.66 | -3.32 | -0.83 | -1.34 | -0.57 |
EPS (Diluted) | -1.44 | -0.71 | -0.50 | -0.78 | -0.50 | -0.35 | -0.41 | -0.17 | -0.08 | -1.14 | -0.59 | -0.45 | -0.76 | -0.65 | -0.13 | -0.55 | -0.60 | -0.66 | -3.32 | -0.83 | -1.33 | -0.57 |
EBITDA | -157.75M | -75.22M | -40.74M | -65.98M | -40.41M | -22.75M | -33.36M | -1.12M | -5.39M | -53.44M | -23.07M | -16.8M | -28.26M | -23.95M | -4.11M | -15.7M | -16.14M | -17.64M | -17.62M | -16.34M | -44.4M | -12.37M |
EBIT | -157.75M | -75.85M | -40.74M | -65.99M | -40.41M | -22.75M | -34.09M | -12.96M | -5.39M | -53.97M | -23.86M | -17.6M | -29.05M | -24.74M | -4.9M | -16.49M | -16.96M | -18.42M | -17.63M | -17.13M | -45.18M | -13.55M |
Depreciation & Amortization | n/a | 631K | n/a | 6.75K | n/a | n/a | 725K | 11.84M | n/a | 527K | 790K | 791K | 790K | 791K | 790K | 790K | 820K | 780K | 4K | 789K | 779K | 1.18M |
Add to Watchlist
Select watchlists to add or remove DFTX